Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Béliveau R[au]:

Search results

Items: 1 to 50 of 245

1.
2.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Demeule M, Beaudet N, Régina A, Besserer-Offroy É, Murza A, Tétreault P, Belleville K, Ché C, Larocque A, Thiot C, Béliveau R, Longpré JM, Marsault É, Leduc R, Lachowicz JE, Gonias SL, Castaigne JP, Sarret P.

J Clin Invest. 2014 Mar;124(3):1199-213. doi: 10.1172/JCI70647. Epub 2014 Feb 17.

3.

Olive oil compounds inhibit vascular endothelial growth factor receptor-2 phosphorylation.

Lamy S, Ouanouki A, Béliveau R, Desrosiers RR.

Exp Cell Res. 2014 Mar 10;322(1):89-98. doi: 10.1016/j.yexcr.2013.11.022. Epub 2013 Dec 8.

PMID:
24326154
4.

MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.

Annabi B, Vaillancourt-Jean E, Béliveau R.

Inflammopharmacology. 2013 Feb;21(1):91-9. doi: 10.1007/s10787-012-0142-8. Epub 2012 Jun 16.

PMID:
22707305
5.

Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent.

Annabi B, Lord-Dufour S, Vézina A, Béliveau R.

Drug Target Insights. 2012;6:1-11. doi: 10.4137/DTI.S9442. Epub 2012 Apr 11.

6.

Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway.

Lamy S, Akla N, Ouanouki A, Lord-Dufour S, Béliveau R.

Exp Cell Res. 2012 Aug 1;318(13):1586-96. doi: 10.1016/j.yexcr.2012.04.004. Epub 2012 Apr 11.

PMID:
22522122
7.

Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.

Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R.

Exp Cell Res. 2012 May 1;318(8):925-35. doi: 10.1016/j.yexcr.2012.02.017. Epub 2012 Feb 26.

PMID:
22394507
8.

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.

Bertrand Y, Currie JC, Poirier J, Demeule M, Abulrob A, Fatehi D, Stanimirovic D, Sartelet H, Castaigne JP, Béliveau R.

Br J Cancer. 2011 Nov 22;105(11):1697-707. doi: 10.1038/bjc.2011.427. Epub 2011 Oct 25.

9.

Colorectal cancer prevention through dietary and lifestyle modifications.

Gingras D, Béliveau R.

Cancer Microenviron. 2011 Aug;4(2):133-9. doi: 10.1007/s12307-010-0060-5. Epub 2011 Jan 13.

10.

Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Annabi B, Vaillancourt-Jean E, Weil AG, Béliveau R.

Onco Targets Ther. 2010 Nov 15;3:219-26. doi: 10.2147/OTT.S14503.

11.

Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells.

Lamy S, Lachambre MP, Lord-Dufour S, Béliveau R.

Vascul Pharmacol. 2010 Nov-Dec;53(5-6):200-8. doi: 10.1016/j.vph.2010.08.002. Epub 2010 Aug 20.

PMID:
20732454
12.

Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice.

Nyalendo C, Sartelet H, Gingras D, Béliveau R.

Anticancer Res. 2010 Jun;30(6):1887-95.

PMID:
20651331
13.

Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.

Annabi B, Doumit J, Plouffe K, Laflamme C, Lord-Dufour S, Béliveau R.

Mol Carcinog. 2010 Jul;49(7):710-7. doi: 10.1002/mc.20645.

PMID:
20564348
14.

New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

Ché C, Yang G, Thiot C, Lacoste MC, Currie JC, Demeule M, Régina A, Béliveau R, Castaigne JP.

J Med Chem. 2010 Apr 8;53(7):2814-24. doi: 10.1021/jm9016637.

PMID:
20210346
15.

Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.

Perry MC, Demeule M, Régina A, Moumdjian R, Béliveau R.

Mol Nutr Food Res. 2010 Aug;54(8):1192-201. doi: 10.1002/mnfr.200900277.

PMID:
20087857
16.

Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.

Nyalendo C, Sartelet H, Barrette S, Ohta S, Gingras D, Béliveau R.

BMC Cancer. 2009 Dec 4;9:422. doi: 10.1186/1471-2407-9-422.

17.

Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.

Provençal M, Berger-Thibault N, Labbé D, Veitch R, Boivin D, Rivard GE, Gingras D, Béliveau R.

J Neurooncol. 2010 May;97(3):365-72. doi: 10.1007/s11060-009-0041-z. Epub 2009 Nov 18.

PMID:
19921488
18.

Transport characteristics of a novel peptide platform for CNS therapeutics.

Bertrand Y, Currie JC, Demeule M, Régina A, Ché C, Abulrob A, Fatehi D, Sartelet H, Gabathuler R, Castaigne JP, Stanimirovic D, Béliveau R.

J Cell Mol Med. 2010 Dec;14(12):2827-39. doi: 10.1111/j.1582-4934.2009.00930.x.

19.

P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.

Dagenais C, Avdeef A, Tsinman O, Dudley A, Beliveau R.

Eur J Pharm Sci. 2009 Sep 10;38(2):121-37. doi: 10.1016/j.ejps.2009.06.009. Epub 2009 Jul 8.

20.

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion.

Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R.

Pharmacol Res. 2009 Nov;60(5):438-45. doi: 10.1016/j.phrs.2009.05.005. Epub 2009 May 23.

PMID:
19467330
21.

Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity.

Gingras D, Béliveau R.

Biochim Biophys Acta. 2010 Jan;1803(1):142-50. doi: 10.1016/j.bbamcr.2009.04.011. Epub 2009 May 4. Review.

22.

c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.

Provençal M, Labbé D, Veitch R, Boivin D, Rivard GE, Sartelet H, Robitaille Y, Gingras D, Béliveau R.

Carcinogenesis. 2009 Jul;30(7):1089-96. doi: 10.1093/carcin/bgp085. Epub 2009 Apr 9.

PMID:
19359592
23.

Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.

Annabi B, Lachambre MP, Plouffe K, Sartelet H, Béliveau R.

Mol Carcinog. 2009 Oct;48(10):910-9. doi: 10.1002/mc.20541.

PMID:
19326372
24.

The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.

Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E, Gingras D, Béliveau R.

Biochemistry. 2009 May 12;48(18):3998-4007. doi: 10.1021/bi900159d.

PMID:
19296573
25.

A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells.

Annabi B, Laflamme C, Sina A, Lachambre MP, Béliveau R.

J Neuroinflammation. 2009 Mar 9;6:8. doi: 10.1186/1742-2094-6-8.

26.

The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration.

Labbé D, Provençal M, Lamy S, Boivin D, Gingras D, Béliveau R.

J Nutr. 2009 Apr;139(4):646-52. doi: 10.3945/jn.108.102616. Epub 2009 Feb 25.

PMID:
19244381
27.

The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation.

Lamy S, Bédard V, Labbé D, Sartelet H, Barthomeuf C, Gingras D, Béliveau R.

Cancer Prev Res (Phila). 2008 Nov;1(6):452-9. doi: 10.1158/1940-6207.CAPR-08-0072.

28.

Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.

Rolland Y, Demeule M, Fenart L, Béliveau R.

Pigment Cell Melanoma Res. 2009 Feb;22(1):86-98. doi: 10.1111/j.1755-148X.2008.00525.x. Epub 2008 Dec 1.

PMID:
19017294
29.

Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.

Nyalendo C, Beaulieu E, Sartelet H, Michaud M, Fontaine N, Gingras D, Béliveau R.

Carcinogenesis. 2008 Aug;29(8):1655-64. doi: 10.1093/carcin/bgn159. Epub 2008 Jul 10.

PMID:
18621744
30.

Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.

Régina A, Demeule M, Ché C, Lavallée I, Poirier J, Gabathuler R, Béliveau R, Castaigne JP.

Br J Pharmacol. 2008 Sep;155(2):185-97. doi: 10.1038/bjp.2008.260. Epub 2008 Jun 23.

31.

Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.

Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, Béliveau R.

Mol Cancer Res. 2008 Jun;6(6):907-16. doi: 10.1158/1541-7786.MCR-07-2184.

32.

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R.

J Neurochem. 2008 Aug;106(4):1534-44. doi: 10.1111/j.1471-4159.2008.05492.x. Epub 2008 May 19.

33.

Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction.

Barakat S, Turcotte S, Demeule M, Lachambre MP, Régina A, Baggetto LG, Béliveau R.

Biochem Biophys Res Commun. 2008 Aug 1;372(3):440-6. doi: 10.1016/j.bbrc.2008.05.012. Epub 2008 May 15.

PMID:
18485890
34.

The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis.

Annabi B, Rojas-Sutterlin S, Laroche M, Lachambre MP, Moumdjian R, Béliveau R.

Mol Nutr Food Res. 2008 Jun;52(6):692-700. doi: 10.1002/mnfr.200700434.

PMID:
18435488
35.

Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.

Lamy S, Beaulieu E, Labbé D, Bédard V, Moghrabi A, Barrette S, Gingras D, Béliveau R.

Carcinogenesis. 2008 May;29(5):1033-41. doi: 10.1093/carcin/bgn070. Epub 2008 Mar 13.

PMID:
18339683
36.

Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.

Provençal M, Michaud M, Beaulieu E, Ratel D, Rivard GE, Gingras D, Béliveau R.

Thromb Haemost. 2008 Mar;99(3):576-85. doi: 10.1160/TH07-10-0623.

PMID:
18327407
37.

Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells.

Gingras D, Michaud M, Di Tomasso G, Béliveau E, Nyalendo C, Béliveau R.

FEBS Lett. 2008 Feb 6;582(3):399-404. doi: 10.1016/j.febslet.2007.12.029. Epub 2007 Dec 28.

38.

Identification and design of peptides as a new drug delivery system for the brain.

Demeule M, Régina A, Ché C, Poirier J, Nguyen T, Gabathuler R, Castaigne JP, Béliveau R.

J Pharmacol Exp Ther. 2008 Mar;324(3):1064-72. Epub 2007 Dec 21.

PMID:
18156463
39.

Reversal of P-glycoprotein-mediated drug efflux by eudesmin from Haplophyllum perforatum and cytotoxicity pattern versus diphyllin, podophyllotoxin and etoposide.

Lim S, Grassi J, Akhmedjanova V, Debiton E, Balansard G, Beliveau R, Barthomeuf C.

Planta Med. 2007 Dec;73(15):1563-7. Epub 2007 Dec 11.

PMID:
18074315
40.

Role of nutrition in preventing cancer.

Béliveau R, Gingras D.

Can Fam Physician. 2007 Nov;53(11):1905-11. Review.

41.

Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.

Desrosiers RR, Beaulieu E, Buchanan M, Béliveau R.

Cell Biochem Biophys. 2007;49(3):182-95. Epub 2007 Oct 9.

PMID:
17952643
42.
43.

Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.

Langlois S, Nyalendo C, Di Tomasso G, Labrecque L, Roghi C, Murphy G, Gingras D, Béliveau R.

Mol Cancer Res. 2007 Jun;5(6):569-83. Epub 2007 May 31.

44.

VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.

Ratel D, Mihoubi S, Beaulieu E, Durocher Y, Rivard GE, Gingras D, Béliveau R.

Thromb Res. 2007;121(2):203-12. Epub 2007 May 21.

45.

Inhibition of tumor growth by a truncated and soluble form of melanotransferrin.

Rolland Y, Demeule M, Michaud-Levesque J, Béliveau R.

Exp Cell Res. 2007 Aug 1;313(13):2910-9. Epub 2007 Apr 14.

PMID:
17493610
46.

Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.

Boivin D, Blanchette M, Barrette S, Moghrabi A, Béliveau R.

Anticancer Res. 2007 Mar-Apr;27(2):937-48.

47.

Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.

Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D, Béliveau R.

J Biol Chem. 2007 May 25;282(21):15690-9. Epub 2007 Mar 27.

48.

Modulation of p-glycoprotein function by caveolin-1 phosphorylation.

Barakat S, Demeule M, Pilorget A, Régina A, Gingras D, Baggetto LG, Béliveau R.

J Neurochem. 2007 Apr;101(1):1-8. Epub 2007 Feb 26.

49.

Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.

Pilorget A, Conesa M, Sarray S, Michaud-Levesque J, Daoud S, Kim KS, Demeule M, Marvaldi J, El Ayeb M, Marrakchi N, Béliveau R, Luis J.

J Cell Physiol. 2007 May;211(2):307-15.

PMID:
17323383
50.

Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells.

Pilorget A, Demeule M, Barakat S, Marvaldi J, Luis J, Béliveau R.

J Neurochem. 2007 Mar;100(5):1203-10.

Supplemental Content

Loading ...
Support Center